We linked health insurance records to cancer registry data to analyze colony-stimulating factor use, finding wide divergence from that recommended by practice guidelines. Objective: To examine ...

The effects of sargramostim and filgrastim on hematopoietic cells are described. Filgrastim is a lineage-specific colonystimulating factor (CSF), mainly affecting neutrophils. In addition to enhancing ...

•Chronic knee swelling ...

Value-based programs, such as the Oncology Care Model (OCM), seek to improve care for patients undergoing chemotherapy, while reducing total costs. The purpose of this study is to quantify the impact ...

Characteristics of a phase II study that predict for a positive phase III trial—A study of 383 clinical trials No significant financial relationships to disclose. This is an ASCO Meeting Abstract from ...

29 Phase I Stage III/IV melanoma pts (16) Intradermal injection of sargramostim into melanoma lesions and normal skin (as a control) for 10 days at four dose levels (10, 20, 40, and 80 µg/day) ...